Hybridoma

By fusing immune B lymphocytes and myeloma cells into hybridoma cells, the resulting hybrid cells have the genetic characteristics of both parent cells, which can secrete antibodies like B lymphocytes and proliferate indefinitely like myeloma cells, successfully overcoming the problem of short survival cycle of B lymphocytes in vitro. Monoclonal antibody can be obtained by culture of hybridoma cells. KYINNO offers a wide range of high-quality antibodies, including hybridoma. Our products have passed purity analysis, stability analysis, affinity and bioactivity verification as well as been used in function assay.